M. Dias Branco 2Q26 net income drops 22% to R$ 168.9 million
Reuters2026/08/13 21:16- M. Dias Branco posted 2Q26 net income of R$ 168.9 million, down 22% from 2Q25.
- EBITDA fell 17.5% to R$ 284.4 million; EBITDA margin narrowed 2.2 percentage points to 10.5%.
- Net sales edged down 0.9% to R$ 2.7 billion, despite sales volume rising 4.4% to 477,000 tonnes.
- Gross margin widened 0.8 percentage points to 34.2% on lower variable costs; SG&A rose 14.3% to R$ 645.9 million.
- Operating cash generation declined 22.6% to R$ 321.8 million; net cash more than doubled to R$ 767 million, equal to -0.7x EBITDA.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Saving in the US, paying globally? Industry research warns: Trump’s push to lower drug prices could instead incentivize pharmaceutical companies to raise prices overseas
A study published in The Lancet indicates that Trump's efforts to lower drug prices in the United States may force pharmaceutical companies to raise prices internationally or exit certain markets, potentially leading to a significant reduction in the approximately $11.6 billion saved annually by Medicare.
Franco-Nevada buys A$170 million Bullabulling gold project royalty from Minerals 260
10-Yr Benchmark Govt Yields - Germany vs Other Nations
Crypto prices
More
